Company / Cash & Equivalents
Inspire Medical Systems, Inc. Cash & Equivalents History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$104.8M
FY2025
5-year range
$104.8M / $441.6M
FY2021-FY2025
Trend
-30.2%
vs FY2024
Sector context
#108 of 148
Health Care
What the data says
At $105M, Inspire Medical Systems, Inc.'s cash & equivalents ranks #108 of 148 in the Health Care sector. Cash & Equivalents has declined for 3 consecutive years, from $442M in FY2022 to $105M in FY2025.
Based on SEC 10-K filings.
$105M in FY2025 with a 5-year CAGR of -11.3%.
Declined from $186M to $105M over the past 2 years.
Health Care sector context is included.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- -38.1%
- 5-Year CAGR
- -11.3%
- 10-Year CAGR
- -
Sector benchmark
#108 of 148 in Health CareTop 73% of 148This company $104.8M Sector average $1.2B
▼
-91.1% below sector average
Key checks
Key Insights
- Inspire Medical Systems, Inc.'s cash & equivalents has declined for 3 consecutive years.
- 5-year CAGR of -11.3%, indicating a declining trend.
- In FY2025, cash & equivalents decreased 30.2% year-over-year.
- Ranks #108 out of 148 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 4.03 (safe zone, above 2.9 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $104.8M | -30.2% |
| FY2024 | $150.2M | -19.1% |
| FY2023 | $185.5M | -58.0% |
| FY2022 | $441.6M | +105.9% |
| FY2021 | $214.5M | +12.6% |
| FY2020 | $190.5M | +733.4% |
| FY2019 | $22.9M | -76.5% |
| FY2018 | $97.3M | +986.4% |
| FY2017 | $9.0M | +34.0% |
| FY2016 | $6.7M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026